This pivotal phase 3 study is currently closed to enrollment. Thank you for your interest and please check back for new study opportunities!
Results from the Phase II trial were recently published:
“A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of rexlemestrocel-L Alone or Combined with Hyaluronic Acid (HA) in Subjects with Chronic Low Back Pain”
Principle Investigator: J. Scott Bainbridge, MD
Sub-Investigators: Drew Trainor, DO; Jadon Redington, PA-C; Sophie Baxter, PA-C
Sponsor: Mesoblast, Ltd.
Condition: Chronic Low Back Pain
Ask your provider about any of our studies, or call our Research Department at 303-327-5511 ext. 319 to find out if you may be a candidate!